Gene · 8726
Papers3,114
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,114
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aberrant activation of a miR-101-UBE2D1 axis contributes to the advanced progression and chemotherapy sensitivity in human hepatocellular carcinoma. | Cell Death Discov | 2024 | 39353886 | PubTator, text mining | PubMed |
| Activation of automethylated PRC2 by dimerization on chromatin. | Mol Cell | 2024 | 39303719 | PubTator, text mining | PubMed |
| Antagonism between H3K27me3 and genome-lamina association drives atypical spatial genome organization in the totipotent embryo. | Nat Genet | 2024 | 39284976 | PubTator, text mining | PubMed |
| Reconstruction of single-cell lineage trajectories and identification of diversity in fates during the epithelial-to-mesenchymal transition. | Proc Natl Acad Sci U S A | 2024 | 39093947 | PubTator, text mining | PubMed |
| H3K27me3-mediated epigenetic regulation in pluripotency maintenance and lineage differentiation. | Cell Insight | 2024 | 39072246 | PubTator, text mining | PubMed |
| Epigenetic modulators provide a path to understanding disease and therapeutic opportunity. | Genes Dev | 2024 | 38914477 | PubTator, text mining | PubMed |
| EZH2-associated tumor malignancy: A prominent target for cancer treatment. | Clin Genet | 2024 | 38881299 | PubTator, text mining | PubMed |
| Molecular insights into regulatory RNAs in the cellular machinery. | Exp Mol Med | 2024 | 38871819 | PubTator, text mining | PubMed |
| Biallelic loss-of-function variants of EZH1 cause a novel developmental disorder with central precocious puberty. | Am J Med Genet A | 2024 | 38814056 | PubTator, text mining | PubMed |
| Making Ramón y Cajal proud: Development of cell identity and diversity in the cerebral cortex. | Neuron | 2024 | 38754415 | PubTator, text mining | PubMed |
| BRG1 programs PRC2-complex repression and controls oligodendrocyte differentiation and remyelination. | J Cell Biol | 2024 | 38652118 | PubTator, text mining | PubMed |
| Targeting EED as a key PRC2 complex mediator toward novel epigenetic therapeutics. | Drug Discov Today | 2024 | 38642703 | PubTator, text mining | PubMed |
| Identification of diagnostic biomarkers and immune cell infiltration in coronary artery disease by machine learning, nomogram, and molecular docking. | Front Immunol | 2024 | 38629070 | PubTator, text mining | PubMed |
| Discovery and Characterization of a Novel Cereblon-Recruiting PRC1 Bridged PROTAC Degrader. | J Med Chem | 2024 | 38607318 | PubTator, text mining | PubMed |
| Bridging structural and cell biology with cryo-electron microscopy. | Nature | 2024 | 38570716 | PubTator, text mining | PubMed |
| Tyrosine 1-phosphorylated RNA polymerase II transcribes PROMPTs to facilitate proximal promoter pausing and induce global transcriptional repression in response to DNA damage. | Genome Res | 2024 | 38467418 | PubTator, text mining | PubMed |
| The molecular basis of cell memory in mammals: The epigenetic cycle. | Sci Adv | 2024 | 38416817 | PubTator, text mining | PubMed |
| FERM domain-containing proteins are active components of the cell nucleus. | Life Sci Alliance | 2024 | 38296350 | PubTator, text mining | PubMed |
| A scalable platform for efficient CRISPR-Cas9 chemical-genetic screens of DNA damage-inducing compounds. | Sci Rep | 2024 | 38291084 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression. | Theranostics | 2024 | 38250042 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8726/papers?page=6